Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
Victòria Ceperuelo‐Mallafré(Instituto de Salud Carlos III), Sonia Fernández‐Veledo(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Rosa Jorba(Institut de Recerca Biomèdica Catalunya Sud), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Joan Vendrell(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), María J. Buzón(Universitat Autònoma de Barcelona), Laia Reverté(Institute for Research and Technology in Food and Agriculture), Teresa Auguet(Institut de Recerca Biomèdica Catalunya Sud), Alicia Gutiérrez‐Valencia(Consejo Superior de Investigaciones Científicas), Montserrat Olona, Elsa Maymó‐Masip(Instituto de Salud Carlos III), Miguel López-Dupla, Ana Madeira(Instituto de Salud Carlos III), Joaquim Peraire(Instituto de Salud Carlos III), Ezequiel Ruíz-Mateos(Apple (Israel))
Cited by 17
Related Papers
SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity
|Nature Immunology|2019|274
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
|Clinical Infectious Diseases|2017|146
Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
|Nature Communications|2019|120